Kerbside

The recommendations provided in this column are taken from various market sources such as brokers, analysts, dealers and investment strategists, etc. These recommendations may not be backed by strong fundamentals. Therefore we advise readers to use their own discretion before investing in these recommendation

RINGING OUT LOUD 

Bharti Airtel
BSE Code: 532454
CMP: Rs.461.60 

Telecom operator Bharti Airtel has shown significant resilience in the course of the ongoing market volatility and exhibited buying momentum on every bounce in the markets, as reported by one of the major broking houses in the country. Further, there are murmurs on the street that they don’t see the pandemic-led lockdown hitting the telecom’s fourth quarter earnings much since it started late-March. Also, the company may report higher revenue, operating profit income and margins for Q4 amidst tariff hike, the first in almost three years. Hence, traders and investors can take exposure in Bharti Airtel for some trading gains. 

SPARKLING AND SHINING 

Colgate-Palmolive India
BSE Code: 500830
CMP: Rs.1335 

The stock of this FMCG major has recovered smartly from the lower levels and the news from the dealers is that it is witnessing smart accumulation from HNIs. If the dealers are to be believed, HNIs are still in an accumulation mode and hoping for some big movement in the stock. Hence, we would recommend traders to trade in this stock with strict stop loss. 

A PROFITABLE CURE 

IPCA Laboratories
BSE Code: 524494
CMP: Rs.1615.80 

If you recall, in our last column we had mentioned that Cadila Healthcare would benefit the most from the current corona virus crisis and that is precisely what has happened. The stock has performed extremely well. Now, from the same source we have got to know that the ‘magical drug’ for treating the viral disease, named Hydroxy Choloroquine (HCQ), manufactured by IPCA Laboratories will lead to a good inflow of investments in the stock by domestic institutional investors and HNIs. Further, this stock has been rock-solid even during the current market mayhem. You too can jump on to the bandwagon and hope to make a quick buck! 

A HOMELY AFFAIR 

Godrej Properties
BSE Code: 533150
CMP: Rs.686.80 

The company in its recent Q4 update reported that it has sold over 3,000 homes in the fourth quarter. The number of homes sold and their value were the highest the company has achieved in any quarter. Further, sales in Q4 included over 500 homes sold in the second half of March as the company focused on digital sales tools to sustain operations despite the lockdown. However, the start of FY21 may be muted due to the lockdown and subsequent subdued economic activity. But it is quite likely that momentum will pick up in the months ahead. Further, the company has a healthy balance-sheet and so it would be prudent to add this stock to your portfolio at its current levels. 

(Closing price as of Apr 08, 2020).